1. Home
  2. KRNY vs CKPT Comparison

KRNY vs CKPT Comparison

Compare KRNY & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRNY
  • CKPT
  • Stock Information
  • Founded
  • KRNY 1884
  • CKPT 2014
  • Country
  • KRNY United States
  • CKPT United States
  • Employees
  • KRNY 556
  • CKPT N/A
  • Industry
  • KRNY Savings Institutions
  • CKPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRNY Finance
  • CKPT Health Care
  • Exchange
  • KRNY Nasdaq
  • CKPT Nasdaq
  • Market Cap
  • KRNY 410.4M
  • CKPT 335.9M
  • IPO Year
  • KRNY 2005
  • CKPT 2017
  • Fundamental
  • Price
  • KRNY $6.34
  • CKPT $4.17
  • Analyst Decision
  • KRNY Buy
  • CKPT Buy
  • Analyst Count
  • KRNY 2
  • CKPT 3
  • Target Price
  • KRNY $7.75
  • CKPT $4.33
  • AVG Volume (30 Days)
  • KRNY 328.5K
  • CKPT 1.1M
  • Earning Date
  • KRNY 04-24-2025
  • CKPT 05-16-2025
  • Dividend Yield
  • KRNY 6.91%
  • CKPT N/A
  • EPS Growth
  • KRNY N/A
  • CKPT N/A
  • EPS
  • KRNY N/A
  • CKPT N/A
  • Revenue
  • KRNY $148,766,000.00
  • CKPT $41,000.00
  • Revenue This Year
  • KRNY $17.60
  • CKPT $102,182.93
  • Revenue Next Year
  • KRNY $22.31
  • CKPT $351.71
  • P/E Ratio
  • KRNY N/A
  • CKPT N/A
  • Revenue Growth
  • KRNY 4.47
  • CKPT N/A
  • 52 Week Low
  • KRNY $5.31
  • CKPT $1.47
  • 52 Week High
  • KRNY $8.59
  • CKPT $4.50
  • Technical
  • Relative Strength Index (RSI)
  • KRNY 53.94
  • CKPT 71.05
  • Support Level
  • KRNY $6.23
  • CKPT $4.02
  • Resistance Level
  • KRNY $6.43
  • CKPT $4.17
  • Average True Range (ATR)
  • KRNY 0.18
  • CKPT 0.03
  • MACD
  • KRNY 0.03
  • CKPT -0.01
  • Stochastic Oscillator
  • KRNY 72.58
  • CKPT 92.86

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.

About CKPT Checkpoint Therapeutics Inc.

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

Share on Social Networks: